Vol. 61 No. 7 (2022): Acta Oncologica

Articles

• Improving survival prediction of oesophageal cancer patients treated with external beam radiotherapy for dysphagia

  Paul M. Jeene, Steven C. Kuijper, Héctor G. van den Boorn, Sherif Y. El Sharouni, Pètra M. Braam, Vera Oppedijk, Rob H. A. Verhoeven, Maarten C. C. M. Hulshof, Hanneke W. M. van Laarhoven

  849-855

  Published: 2022-07-03

  • PDF

• Trends in end-of-life decisions among patients dying in a university hospital oncology ward after implantation of a palliative outpatient clinic

  Anna-Maria Tolppanen, Annamarja Lamminmäki, Helena Länsimies, Vesa Kataja, Kristiina Tyynelä-Korhonen

  881-887

  Published: 2022-07-03

  • PDF

• Characteristics and survival of patients with non-small cell lung cancer treated with immune-checkpoint inhibitors in the real-world: experiences from Bergen, Norway

  Fabian Gärtner, Jörg Aßmus, Øystein Fløtten, Maria Paula Ramnefjell, Marianne Aanerud

  814-818

  Published: 2022-07-03

  • PDF

• Radiotherapy respiratory motion management in hepatobiliary and pancreatic malignancies: a systematic review of patient factors influencing effectiveness of motion reduction with abdominal compression

  Mairead Daly, Alan McWilliam, Ganesh Radhakrishna, Ananya Choudhury, Cynthia L. Eccles

  833-841

  Published: 2022-07-03

  • PDF

• Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial

  Ellen Backlund, Muyi Yang, Vitali Grozman, Giuseppe Masucci, Johan Falkenius, Hanna Eriksson, Braslav Jovanovic, Katarina Hammarlund, Ulf Isacsson, Calin Radu, Edvard Abel, Kristin Karlsson, Ricardo Palanco Zamora, Peter Wersäll, Ulrika Edbäck, Stina Wickström, Eva Darai Ramqvist, Suzanne Egyhazi Brage, Rolf Kiessling, Kristina Viktorsson, Bo Franzén, Rolf Lewensohn, Roger Olofsson Bagge, Gustav J. Ullenhag, Lars Ny, Karin Lindberg, Hildur Helgadottir

  869-873

  Published: 2022-07-03

  • PDF

• Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based study

  Kjetil Boye, Ingvild Lobmaier, Marthe Rosvoll Kobbeltvedt, Joachim Thorkildsen, Ingeborg Taksdal, Bodil Bjerkehagen, Øyvind S. Bruland, Olga Zaikova, Kirsten Sundby Hall, Ivar Hompland

  793-800

  Published: 2022-07-03

  • PDF

• Outcome in PCNSL patients and its association with PD-L1+ leukocytes in the tumor microenvironment

  Maysaa Abdulla, Peter Hollander, Cecilia Lindskog, Christer Sundström, Gunilla Enblad, Leonie Saft, Rose-Marie Amini

  824-829

  Published: 2022-07-03

  • PDF

• Assessment of gene expressions from squamous cell carcinoma of the head and neck to predict radiochemotherapy-related xerostomia and dysphagia

  Noorazrul Yahya, Annett Linge, Karoline Leger, Till Maile, Max Kemper, Dominik Haim, Korinna Jöhrens, Esther G. C. Troost, Mechthild Krause, Steffen Löck

  856-863

  Published: 2022-07-03

  • PDF

• Long-term resource utilisation and associated costs of exercise during (neo)adjuvant oncological treatment: the Phys-Can project

  Anna-Karin Ax, Magnus Husberg, Birgitta Johansson, Ingrid Demmelmaier, Sveinung Berntsen, Katarina Sjövall, Sussanne Börjeson, Karin Nordin, Thomas Davidson

  888-896

  Published: 2022-07-03

  • PDF

• Cancer in young adulthood – classifying the intensity of treatment

  C. Hedman, J. Ahlgren, K. E. Smedby, K. Hellman, R. Henriksson, O. Ståhl, L. Wettergren, C. Lampic

  809-813

  Published: 2022-07-03

  • PDF

• Cluster model incorporating heterogeneous dose distribution of partial parotid irradiation for radiotherapy induced xerostomia prediction with machine learning methods

  Ming Chao, Issam El Naqa, Richard L. Bakst, Yeh-Chi Lo, José A. Peñagarícano

  842-848

  Published: 2022-07-03

  • PDF

• Advanced cancer and concomitant dementia: access to specialized palliative care, emergency room, hospital care, and place of death

  Per Fürst, Peter Strang, Christel Hedman, Torbjörn Schultz

  874-880

  Published: 2022-07-03

  • PDF

• Real-life incidence of cardiotoxicity and associated risk factors in sarcoma patients receiving doxorubicin

  Joanna Vitfell-Rasmussen, Anders Krarup-Hansen, Merete Vaage-Nilsen, Thomas Kümler, Bo Zerahn

  801-808

  Published: 2022-07-03

  • PDF

• A rare case of erythema dyschromicum perstans arising in the setting of a third-generation tyrosine kinase inhibitor

  Ahava Muskat, Lauren Hoffman, Yana Kost, Daiva M. Mattis, Bijal Amin, Beth N. McLellan

  830-832

  Published: 2022-07-03

  • PDF

• Accuracy of stopping power ratio calculation and experimental validation of proton range with dual-layer computed tomography

  Vadim P. Moskvin, Fakhriddin Pirlepesov, Yue Yan, Ozgur Ates, William J. Myers, Jinsoo Uh, Li Zhao, Nadav Shapira, Yoad Yagil, Thomas E. Merchant, Chia-ho Hua

  864-868

  Published: 2022-07-03

  • PDF

• Early intervention with compression garments prevents progression in mild breast cancer-related arm lymphedema: a randomized controlled trial

  Katarina Y. Blom, Karin I. Johansson, Lena B. Nilsson-Wikmar, Christina B. Brogårdh

  897-905

  Published: 2022-07-03

  • PDF

• Ovarian tumor frozen section, a multidisciplinary affair

  Mihaela Asp, Ebba Peber, Päivi Kannisto, Anna Måsbäck, Susanne Malander

  785-792

  Published: 2022-07-03

  • PDF

• Practical lessons from treating medullary thyroid carcinoma patients harboring a RET-alteration: Pralsetinib-induced acute confusional state

  Eliya Shachar, Shira Peleg Hasson, Deborah T. Blumenthal, Meerav Fraenkel, Yoel Uri, Ido Wolf, Simona Grozinsky-Glasberg

  819-823

  Published: 2022-07-03

  • PDF